Anti-TNF-α therapies have shown high therapeutic efficacy against RA, and the following five drugs are currently available: infliximab, etanercept, adalimumab, golimumab, and certolizumab3,5–7. This evidence concerns the gene TNF and rheumatoid arthritis.